Recombinant multi-epitope antigen of bovine coronavirus and application thereof
A coronavirus and multi-epitope technology, applied in the fields of molecular biology and immunology, can solve the problems of genetic variation vaccine efficacy, economic loss and loss of cattle breeding, and achieve the goal of improving prokaryotic expression efficiency and preventing virus from infecting animals Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Example 1: Screening of BCoV S protein epitopes and design and synthesis of multi-epitope proteins
[0039]According to the literature reports on NCBI and the S gene sequence of bovine coronavirus epidemic strains published in the Genebank database, the recombinant antigenic epitope BCoV-double-S1-S2 was designed, and two well-conserved S proteins were selected at the same time. Antigen epitopes S1 and S2, S1 and S2 are repeated in series, and each epitope is connected by 4GS-4GS flexible amino acids. At the same time, the nucleotide sequence encoding the recombinant antigenic epitope BCoV-double-S1-S2 was optimized with reference to the Escherichia coli codon preference table to improve its prokaryotic expression efficiency. Finally, EcoR I and Not I restriction endonuclease sites and protective bases were added to both ends of the sequence of the recombinant antigenic epitope BCoV-double-S1-S2, and the recombinant antigenic epitope was synthesized by genetic engineeri...
Embodiment 2
[0050] Example 2: Construction and Identification of BCoV S Protein Antigen Epitope Recombinant Expression Vector
[0051] The prokaryotic expression vector pET-28a(+) and BCoV S protein antigen epitope concatenation were double-digested with EcoR I and Not I restriction enzymes, and the vector fragment and the target gene fragment were respectively recovered, and the target gene fragment was lysed with T4DNA ligase Connected to the pET-28a(+) vector, transformed into BL21(DE3) competent cells, picked a single colony identified as positive by double enzyme digestion, and sent it to Beijing Liuhe Huada Gene Technology Co., Ltd. for sequencing.
[0052] The identification results of BCoV S protein antigen epitope recombinant expression vector construction are as follows: figure 2 shown by figure 2 It can be seen that M is a Marker with a molecular size of 10000bp, 1 is the map of the recombinant expression plasmid after enzyme digestion, the upper band is pET-28a(+), the size...
Embodiment 3
[0053] Embodiment 3: the establishment of BCoV indirect ELISA detection method
[0054] BCoV S protein recombinant antigen epitope induces expression of purified protein as antigen, coats 96-well plate with different protein concentrations of 0.1-10 μg / ml, uses BCoV positive bovine serum as primary antibody, and calf negative serum as primary antibody Anti-negative control, diluted according to the ratio of 1:20, 1:50, 1:80, 1:100, 1:200, 1:400, forming a matrix with protein dilution, HRP-rabbit anti-bovine IgG diluted 1:5000 As the secondary antibody, explore the optimal concentration of protein and primary antibody. Among them, the optimal concentration of protein coating is 0.30 μg / ml, and the detection effect is the best when the serum dilution concentration is 1:100. Preliminary establishment of BCoV indirect ELISA detection method.
[0055] Judgment result: the absorbance value of blank control and negative serum wells is less than 0.2, and the result is valid when the...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com